Literature DB >> 17691931

Statins exert multiple beneficial effects on patients undergoing percutaneous revascularization procedures.

Kosmas I Paraskevas1, Vasilios G Athyros, Despina D Briana, Anna I Kakafika, Asterios Karagiannis, Dimitri P Mikhailidis.   

Abstract

BACKGROUND AND AIMS: Statins are an essential component of the therapeutic approach of patients with atherosclerotic disease. Statin use is also associated with improved peri-operative and long-term outcomes in these patients. We aimed to define the role of statin treatment in patients undergoing percutaneous revascularization procedures. LITERATURE SEARCH
METHOD: We searched Medline for studies assessing the effect of statin treatment on percutaneous interventions. LITERATURE SEARCH
RESULTS: Early statin treatment is associated with improved outcomes in patients undergoing percutaneous coronary intervention procedures. Current evidence implies that statin treatment may also play a beneficial role in the management of patients undergoing percutaneous renal artery revascularization and endovascular abdominal aortic aneurysm repair, carotid angioplasty/stenting and endovascular peripheral arterial interventions.
CONCLUSIONS: Preliminary data suggest that statins exert multiple beneficial actions in patients undergoing percutaneous interventions. Future randomized trials are expected to further evaluate the beneficial effects of statins in these procedures.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17691931     DOI: 10.2174/138945007781386893

Source DB:  PubMed          Journal:  Curr Drug Targets        ISSN: 1389-4501            Impact factor:   3.465


  10 in total

1.  GPIIb/IIIa Receptor Antagonism Using Small Molecules Provides no Additive Long-Term Protection after Percutaneous Coronary Intervention as Compared to Clopidogrel Plus Aspirin.

Authors:  Michele Schiariti; Angela Saladini; Francesco Papalia; Placido Grillo; Cristina Nesta; Domenico Cuturello; Bindo Missiroli; Paolo Emilio Puddu
Journal:  Open Cardiovasc Med J       Date:  2010-07-20

Review 2.  Statin therapy in peritoneal dialysis patients: effects beyond lipid lowering.

Authors:  Kosmas I Paraskevas
Journal:  Int Urol Nephrol       Date:  2007-12-08       Impact factor: 2.370

3.  Statins inhibit pulmonary artery smooth muscle cell proliferation by upregulation of HO-1 and p21WAF1.

Authors:  Manxiang Li; Yuan Liu; Hongyang Shi; Yonghong Zhang; Guizuo Wang; Jing Xu; Jiamei Lu; Dexin Zhang; Xinming Xie; Dong Han; Yuanyuan Wu; Shaojun Li
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2012-07-22       Impact factor: 3.000

4.  The role of nerve growth factor in the prophylaxis and treatment of diabetic foot ulcers.

Authors:  Elisavet K Tiaka; Nikolaos Papanas; Anastassios C Manolakis; Efstratios Maltezos
Journal:  Int J Burns Trauma       Date:  2011-09-03

Review 5.  Atherosclerosis and osteoporosis: age-dependent degenerative processes or related entities?

Authors:  P Anagnostis; A Karagiannis; A I Kakafika; K Tziomalos; V G Athyros; D P Mikhailidis
Journal:  Osteoporos Int       Date:  2008-05-29       Impact factor: 4.507

6.  Increased fluorodeoxyglucose uptake following endovascular abdominal aortic aneurysm repair: a predictor of endoleak?

Authors:  Kosmas I Paraskevas; Alexandros A Tzovaras; Vassilios Stathopoulos; Fotini Gentimi; Dimitri P Mikhailidis
Journal:  Open Cardiovasc Med J       Date:  2010-04-08

Review 7.  Is There Still a Role for Glycoprotein IIb/IIIa Antagonists in Acute Coronary Syndromes?

Authors:  Loredana Iannetta; Paolo Emilio Puddu; Domenico Cuturello; Angela Saladini; Mariano Pellicano; Michele Schiariti
Journal:  Cardiol Res       Date:  2013-03-08

8.  Effects of preoperative statin use on perioperative outcomes of carotid endarterectomy.

Authors:  Enzo Ballotta; Antonio Toniato; Filippo Farina; Claudio Baracchini
Journal:  Brain Behav       Date:  2016-11-05       Impact factor: 2.708

9.  Determinants of microbial load in infected diabetic foot ulcers: a pilot study.

Authors:  M Demetriou; N Papanas; M Panopoulou; K Papatheodorou; E Maltezos
Journal:  Int J Endocrinol       Date:  2013-06-26       Impact factor: 3.257

10.  Statin drugs mitigate cellular inflammatory response after ST elevation myocardial infarction, but do not affect in-hospital mortality.

Authors:  Leili Pourafkari; Ognjen Visnjevac; Samad Ghaffari; Nader D Nader
Journal:  J Cardiovasc Thorac Res       Date:  2016-03-15
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.